NRIX financials
Nurix Therapeutics (NRIX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NRIX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $83.98M | $65.12M | -$285.67M | -$264.46M | -3.05 |
| 2024 | $54.55M | -$167.08M | -$213.03M | -$193.57M | -2.88 |
| 2023 | $76.99M | -$112.16M | -$155.06M | -$143.95M | -2.65 |
| 2022 | $38.63M | -$145.87M | -$183.87M | -$180.36M | -3.71 |
| 2021 | $29.75M | -$86.68M | -$117.89M | -$117.19M | -2.73 |
| 2020 | $17.82M | -$48.67M | -$64.98M | -$43.24M | -2.76 |
- NRIX revenue was $83.98M in fiscal 2025, net income -$264.46M.
Updated 2026-11-07 11:56 UTC